๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Phase I trial of ImuVert (natural membrane vesicles associated with ribosomes) in patients with advanced cancer

โœ Scribed by Abraham Mittelman; Richard Urban; George Wong; Tauseef Ahmed; Zalmen Arlin

Publisher
Springer-Verlag
Year
1992
Tongue
English
Weight
448 KB
Volume
35
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Phase I trial of extracellular adenosine
Phase I trial of extracellular adenosine 5โ€ฒ-triphosphate in patients with advanced cancer
โœ Haskell, Charles M.; Wong, Maylene; Williams, Adrian; Lee, Le-Young ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 883 KB

Adenosine 5'-triphosphate (ATP) has antineoplastic activity in vitro and in murine tumor systems, but there are no data in humans defining its potential use as an antineoplastic agent. We conducted a Phase I study to determine the spectrum of toxicity, maximum safely tolerated dose (MTD), and pharma

Long-term intravenous hydroxyurea infusi
Long-term intravenous hydroxyurea infusions in patients with advanced cancer. A phase I trial
โœ Martin S. Blumenreich; Michael J. Kellihan; U. Geetha Joseph; Kim A. Lalley; Eli ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 384 KB ๐Ÿ‘ 1 views

Background. Hydroxyurea is an S-phase specific drug. Constant exposure of tumor cells with a low Sphase fraction to the agent may result in improved cell kill. Because of its short half-life, a continuous intravenous infusion may result in better tumor exposure than intake by mouth. The goal of this